Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/03/2856953/0/en/Surrozen-Publishes-Study-in-Respiratory-Research-Demonstrating-the-Promise-of-a-Wnt-Mimetic-Antibody-in-Treating-Pulmonary-Fibrosis.html
https://www.globenewswire.com/news-release/2024/04/01/2855190/0/en/Surrozen-Announces-Safety-Pharmacodynamic-and-Liver-Function-Data-for-SZN-043.html
https://www.globenewswire.com/news-release/2024/04/01/2855188/0/en/Surrozen-Announces-up-to-192-5-Million-Private-Placement-of-Securities-Priced-At-the-Market-Under-Nasdaq-Rules.html
https://www.globenewswire.com//news-release/2024/01/18/2811530/0/en/Surrozen-Provides-Corporate-Update-on-Clinical-Programs.html
https://www.fiercebiotech.com/biotech/surrozen-stops-ibd-program-due-dose-concerns-and-competition
https://www.globenewswire.com//news-release/2023/11/08/2776688/0/en/Surrozen-Provides-Third-Quarter-2023-Financial-Results.html
https://www.fiercebiotech.com/biotech/surrozen-culls-least-two-research-programs-funnel-more-money-toward-clinical-work
https://www.globenewswire.com/news-release/2023/08/09/2722112/0/en/Surrozen-Provides-Second-Quarter-2023-Financial-Results.html
https://www.globenewswire.com/news-release/2023/06/05/2681951/0/en/Surrozen-Publishes-Study-in-Nature-Communications-Demonstrating-the-Promise-of-a-Fzd4-Wnt-Antibody-in-Treating-Ischemic-Stroke.html
https://www.globenewswire.com/news-release/2023/05/10/2666025/0/en/Surrozen-Provides-First-Quarter-2023-Financial-Results-and-Corporate-and-Pipeline-Updates.html